A comprehensive proteomic analysis identified that the expression of hepatocyte growth factor-regulated tyrosine kinase substrate (HGS) increases concomitantly with CRC tumorigenesis and is an independent poor prognostic factor, which may present itself as a novel biomarker and target for therapeutic interventions in CRC [83]. This evidence concerns the gene HGS and colorectal carcinoma.